KHN Morning Briefing

Summaries of health policy coverage from major news organizations.

Major Maker Of Generic Lipitor Halts Production

The New York Times: Maker Of Generic Lipitor Halts Production
Ranbaxy Pharmaceuticals, the largest producer of the generic version of Lipitor, has halted production of the drug until it can figure out why glass particles may have ended up in pills that were distributed to the public, the Food and Drug Administration announced Thursday. The agency said it had not received any reports of patients being harmed by the particles, which are about the size of a grain of sand. Earlier this month, Ranbaxy recalled more than 40 lots of the drug because of the glass contamination (Thomas, 11/29).

This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.